Caterina Cancrini Selected Research

Wiskott-Aldrich Syndrome

2/2013	Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
4/2009	The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Cancrini Research Topics

Disease

11	Infections 01/2022 - 03/2002
7	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2024 - 10/2010
4	Severe combined immunodeficiency due to adenosine deaminase deficiency 02/2024 - 10/2010
4	Lymphopenia (Lymphocytopenia) 01/2022 - 01/2017
4	Cytopenia 01/2020 - 01/2018
4	Ectodermal Dysplasia (Aplasia Cutis Congenita) 01/2018 - 10/2003
3	Eosinophilia 01/2023 - 02/2021
3	Virus Diseases (Viral Diseases) 02/2022 - 11/2015
3	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 01/2020
3	COVID-19 01/2022 - 11/2020
3	Neoplasms (Cancer) 12/2021 - 01/2021
3	Disease Progression 12/2021 - 03/2002
3	IgA Deficiency 01/2021 - 12/2002
3	Bacterial Infections (Bacterial Infection) 01/2019 - 10/2003
2	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2023 - 01/2021
2	Asthma (Bronchial Asthma) 01/2023 - 12/2015
2	Inflammation (Inflammations) 01/2023 - 01/2018
2	Anaphylaxis (Anaphylactic Shock) 01/2023 - 12/2015
2	Reinfection 01/2022 - 02/2013
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2019
2	Opportunistic Infections (Opportunistic Infection) 01/2021 - 01/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2021
2	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2021
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 07/2019
2	Evans Syndrome 01/2020 - 07/2019
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2020 - 07/2019
2	Job Syndrome (Hyper-IgE Syndrome) 07/2019 - 02/2010
2	Exanthema (Rash) 07/2019 - 02/2010
2	hypohidrotic Ectodermal dysplasia with immune deficiency 01/2018 - 10/2003
2	Wiskott-Aldrich Syndrome 02/2013 - 04/2009
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2024
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024
1	Thyroid Neoplasms (Thyroid Cancer) 10/2023
1	Eczema 04/2023
1	Abscess 04/2023
1	Epstein-Barr Virus Infections 03/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2023
1	Food Hypersensitivity (Food Allergy) 01/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Skin Diseases (Skin Disease) 01/2023
1	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 06/2022
1	Dermatitis 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Macrophage Activation Syndrome 01/2022
1	Chronic Granulomatous Disease 01/2022
1	Cytochrome B-Negative Autosomal Recessive Chronic Granulomatous Disease 01/2022
1	Necrotizing Pneumonia 01/2022
1	Histiocytosis 01/2022
1	Hereditary Complement Deficiency Diseases 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Genetic Risk Score 01/2022
1	Colitis 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 12/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021
1	Visceral Leishmaniasis (Kala Azar) 01/2021
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 01/2021

Drug/Important Bio-Agent (IBA)

7	Immunoglobulin E (IgE)IBA 01/2023 - 02/2010
5	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2009
5	Immunoglobulin M (IgM)IBA 01/2022 - 12/2002
4	SteroidsIBA 01/2022 - 12/2015
3	Adenosine DeaminaseIBA 02/2024 - 06/2011
3	Rituximab (Mabthera)FDA Link 01/2022 - 07/2019
3	LigandsIBA 01/2021 - 10/2003
3	VaccinesIBA 01/2021 - 09/2016
3	EnzymesIBA 12/2020 - 10/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2013
3	I-kappa B KinaseIBA 07/2010 - 10/2003
2	Busulfan (Busulfex)FDA Link 02/2024 - 10/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2022
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2017
2	Monoclonal AntibodiesIBA 01/2022 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2002
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021 - 01/2021
2	AntibodiesIBA 09/2018 - 11/2015
2	Serine (L-Serine)FDA Link 01/2018 - 10/2003
2	NF-kappa B (NF-kB)IBA 07/2006 - 10/2003
2	NF-KappaB Inhibitor alphaIBA 07/2006 - 10/2003
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2006 - 05/2005
1	Therapeutic UsesIBA 10/2023
1	STAT6 Transcription FactorIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	B-Cell Activation Factor ReceptorIBA 01/2022
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 01/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	remdesivirIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2021
1	Abatacept (Orencia)FDA Link 12/2021

Therapy/Procedure

10	Therapeutics 04/2023 - 12/2017
4	Transplantation 01/2021 - 07/2006
4	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2006
2	Cell Transplantation 07/2019 - 10/2012
2	Stem Cell Transplantation 04/2017 - 07/2006
1	Aftercare (After-Treatment) 04/2024
1	Precision Medicine 06/2022
1	Gastrectomy 12/2021